Copyright
©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 105219
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.105219
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.105219
Table 1 Comparison of the baseline characteristics, mean ± SD
Variables | Con group (n = 20, ITT analysis) | Con group (n = 17, PP analysis) | XQG group (n = 20, ITT or PP analysis) |
Sex (male/female) | 8/12 | 7/10 | 5/15 |
Age (year) | 51.10 ± 10.88 | 52.65 ± 10.52 | 51.65 ± 12.56 |
DD (month) | 52.25 ± 53.32 | 56.18 ± 56.39 | 33.55 ± 33.35 |
BMI (kg/m2) | 23.15 ± 3.09 | 23.06 ± 3.24 | 23.64 ± 4.08 |
SBP (mmHg) | 120.85 ± 12.71 | 120.18 ± 13.50 | 119.30 ± 15.20 |
DBP (mmHg) | 77.50 ± 8.68 | 76.65 ± 8.93 | 79.05 ± 8.74 |
FPG (mmol/L) | 6.48 ± 0.47 | 6.48 ± 0.49 | 6.26 ± 0.47 |
2hPG (mmol/L) | 10.20 ± 3.34 | 10.42 ± 3.51 | 9.71 ± 2.03 |
HbA1c (%) | 5.97 ± 0.48 | 5.95 ± 0.31 | 5.92 ± 0.33 |
FINS (μIU/mL) | 9.23 ± 4.90 | 9.52 ± 5.27 | 15.07 ± 12.46 |
HOMA-IR | 2.67 ± 1.47 | 2.76 ± 1.59 | 4.15 ± 3.28 |
ALT (TU/L) | 22.15 ± 9.90 | 23.22 ± 10.22 | 26.76 ± 17.52 |
AST (U/L) | 21.83 ± 4.43 | 22.29 ± 4.62 | 24.99 ± 7.44 |
BUN (mg/dL) | 5.03 ± 1.20 | 5.19 ± 1.22 | 5.61 ± 0.96 |
Cr (mg/dL) | 61.50 ± 10.60 | 61.14 ± 10.85 | 64.46 ± 15.71 |
- Citation: Zhao JD, Guo MZ, Zhang Y, Zhu SH, Wang YT, Zhang YP, Liu X, Cheng S, Wang F, Xu Q, Ruan NB, Fang ZH. Efficacy of Xiaokeqing granules and lifestyle intervention in treating prediabetes mellitus considering metabolomic biomarkers: A randomised controlled trial. World J Diabetes 2025; 16(7): 105219
- URL: https://www.wjgnet.com/1948-9358/full/v16/i7/105219.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i7.105219